Meitav Dash Investments LTD Abbott Laboratories Transaction History

Meitav Dash Investments LTD

$5.8 Billion
Q3 2024

A detailed history of Meitav Dash Investments LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Meitav Dash Investments LTD holds 10,000 shares of ABT stock, worth $1.17 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

10,000

Previous 15,000 33.33%

Holding current value

$1.17 Million

Previous $1.56 Million 26.83%

% of portfolio

0.02%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$100.07 - $118.13 $500,349 - $590,650	-5,000 Reduced 33.33%	10,000 $1.14 Million
Q3 2023 Oct 30, 2023	SELL	$95.53 - $114.62 $176,348 - $211,588	-1,846 Reduced 10.96%	15,000 $1.45 Million
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $1.51 Million - $1.68 Million	15,000 Added 812.57%	16,846 $1.84 Million
Q2 2023 Jul 24, 2023	SELL	$100.78 - $112.29 $1.51 Million - $1.69 Million	-15,029 Reduced 89.06%	1,846 $201,000
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $8,717 - $10,260	-90 Reduced 0.53%	16,875 $1.71 Million
Q4 2022 Feb 06, 2023	SELL	$95.06 - $111.52 $1,235 - $1,449	-13 Reduced 0.08%	16,965 $1.86 Million
Q3 2022 Oct 31, 2022	BUY	$96.76 - $112.03 $87,374 - $101,163	903 Added 5.62%	16,978 $1.67 Million
Q2 2022 Aug 01, 2022	SELL	$102.07 - $123.37 $364,900 - $441,047	-3,575 Reduced 18.19%	16,075 $1.75 Million
Q4 2021 Feb 08, 2022	BUY	$115.53 - $141.46 $1.09 Million - $1.33 Million	9,400 Added 91.71%	19,650 $2.77 Million
Q3 2021 Nov 03, 2021	BUY	$116.66 - $129.06 $9,332 - $10,324	80 Added 0.79%	10,250 $1.22 Million
Q2 2021 Aug 05, 2021	SELL	$105.79 - $124.53 $18.4 Million - $21.7 Million	-174,013 Reduced 94.48%	10,170 $1.19 Million
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $146,607 - $172,725	1,347 Added 0.74%	184,183 $22.1 Million
Q4 2020 Feb 02, 2021	SELL	$105.0 - $114.42 $4.04 Million - $4.4 Million	-38,447 Reduced 17.37%	182,836 $20 Million
Q3 2020 Nov 05, 2020	SELL	$91.64 - $111.29 $7,147 - $8,680	-78 Reduced 0.04%	221,283 $24.1 Million
Q2 2020 Aug 10, 2020	BUY	$76.57 - $98.0 $7.39 Million - $9.46 Million	96,500 Added 77.29%	221,361 $20.2 Million
Q1 2020 May 11, 2020	BUY	$62.82 - $91.86 $7.84 Million - $11.5 Million	124,861 New	124,861 $9.85 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $581,582 - $658,849	-8,871 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$60.81 - $73.36 $277,415 - $334,668	-4,562 Reduced 33.96%	8,871 $651,000
Q2 2018 Aug 14, 2018	SELL	$57.57 - $63.54 $147,436 - $162,725	-2,561 Reduced 16.01%	13,433 $819,000
Q1 2018 May 15, 2018	BUY	$56.27 - $63.62 $899,982 - $1.02 Million	15,994 New	15,994 $958,000

Others Institutions Holding ABT

# of Institutions

3,198

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

News

Stay updated on Meitav Dash Investments LTD with notifications on news.

Account

Meitav Dash Investments LTD Abbott Laboratories Transaction History